Abiopharma

🔍 Sahai Avanish (Director)

Company: Plum Acquisition Corp, IV (PLMK)

Report Date: 2026-07-09

Detailed Transactions and Holdings:

• Acquired 25,000 shares of Class A ordinary shares (Direct)
  Date: 2026-07-09 | Code: C | equity_swap_involved: 0 | shares_owned_after: 25,000.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
• Sold 25,000 shares of Class B ordinary shares (Derivative)
  Date: 2026-07-09 | Code: C | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F3, F1, F1, F2, F2

Footnotes:

• F1: Each Class B ordinary share, par value $0.0001, ("Class B Shares") will automatically convert into Class A ordinary shares, par value $0.0001, of the Issuer ("Class A Shares") at a ratio of no less than one-to-one following the consummation of the Issuer's initial business combination, or earlier at the option of the holder thereof, subject to adjustment as set forth in the Issuer's registration statement on Form S-1 (File No. 333-281144). The Class B Shares have no expiration date.
• F2: The shares are held by Karnavy Sahai Trust, of which the Reporting Person is the trustee.
• F3: The reported Class B Shares converted into Class A Shares pursuant to an election by the Reporting Person.